The present disclosure provides SPNS2 inhibitor compounds according to Formula (I) and their pharmaceutically acceptable salts, and/or tautomers as described in the disclosure, and the disclosure provides their pharmaceutical compositions and methods of use in therapy.
本公开提供了符合公式(I)的
SPNS2
抑制剂化合物及其药学上可接受的盐和/或互变异构体,如本公开所述,并提供了它们的药物组合物和在治疗方面使用的方法。